DE60323943D1 - Immobilisierte bioaktive hydrogel matrizen für oberflächenbeschichtungen - Google Patents

Immobilisierte bioaktive hydrogel matrizen für oberflächenbeschichtungen

Info

Publication number
DE60323943D1
DE60323943D1 DE60323943T DE60323943T DE60323943D1 DE 60323943 D1 DE60323943 D1 DE 60323943D1 DE 60323943 T DE60323943 T DE 60323943T DE 60323943 T DE60323943 T DE 60323943T DE 60323943 D1 DE60323943 D1 DE 60323943D1
Authority
DE
Germany
Prior art keywords
molecular weight
high molecular
bioactive hydrogel
surface coatings
hydrogel matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60323943T
Other languages
English (en)
Inventor
Francis V Lamberti
Richard Chris Klann
Ronald Stewart Hill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Encelle Inc
Original Assignee
Encelle Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Encelle Inc filed Critical Encelle Inc
Application granted granted Critical
Publication of DE60323943D1 publication Critical patent/DE60323943D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/025—Other specific inorganic materials not covered by A61L27/04 - A61L27/12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
    • B29C39/003—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor characterised by the choice of material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/112—Phosphorus-containing compounds, e.g. phosphates, phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/04—Coatings containing a composite material such as inorganic/organic, i.e. material comprising different phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/06—Coatings containing a mixture of two or more compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor
    • B29L2031/7532—Artificial members, protheses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2913—Rod, strand, filament or fiber
    • Y10T428/2933—Coated or with bond, impregnation or core
    • Y10T428/294—Coated or with bond, impregnation or core including metal or compound thereof [excluding glass, ceramic and asbestos]
    • Y10T428/2942—Plural coatings
    • Y10T428/2947—Synthetic resin or polymer in plural coatings, each of different type
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31551—Of polyamidoester [polyurethane, polyisocyanate, polycarbamate, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31786—Of polyester [e.g., alkyd, etc.]
DE60323943T 2002-02-21 2003-02-21 Immobilisierte bioaktive hydrogel matrizen für oberflächenbeschichtungen Expired - Lifetime DE60323943D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35862502P 2002-02-21 2002-02-21
PCT/US2003/005072 WO2003072157A1 (en) 2002-02-21 2003-02-21 Immobilized bioactive hydrogel matrices as surface coatings

Publications (1)

Publication Number Publication Date
DE60323943D1 true DE60323943D1 (de) 2008-11-20

Family

ID=27765970

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60325827T Expired - Lifetime DE60325827D1 (de) 2002-02-21 2003-02-21 Vernetzte bioaktive hydrogel-matrizen
DE60323943T Expired - Lifetime DE60323943D1 (de) 2002-02-21 2003-02-21 Immobilisierte bioaktive hydrogel matrizen für oberflächenbeschichtungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60325827T Expired - Lifetime DE60325827D1 (de) 2002-02-21 2003-02-21 Vernetzte bioaktive hydrogel-matrizen

Country Status (10)

Country Link
US (9) US7303814B2 (de)
EP (2) EP1476202B1 (de)
JP (2) JP4624678B2 (de)
AT (2) ATE420672T1 (de)
AU (2) AU2003213253B2 (de)
CA (2) CA2476656C (de)
DE (2) DE60325827D1 (de)
ES (2) ES2318115T3 (de)
NZ (2) NZ535136A (de)
WO (2) WO2003072157A1 (de)

Families Citing this family (293)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050163818A1 (en) * 1996-11-05 2005-07-28 Hsing-Wen Sung Drug-eluting device chemically treated with genipin
US20040081704A1 (en) 1998-02-13 2004-04-29 Centerpulse Biologics Inc. Implantable putty material
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
WO2003030957A1 (de) * 2001-10-11 2003-04-17 Straumann Holding Ag Osteophile implantate
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
US20080086792A1 (en) 2006-10-13 2008-04-17 Thomas Charles Kuracina Method and apparatus for diverting sweat, liquid, moisture or the like from an eye
JP4624678B2 (ja) * 2002-02-21 2011-02-02 パイオニア・サージカル・オーソバイオロジックス，インコーポレイテッド 架橋生物活性ヒドロゲルマトリックス
GB0212667D0 (en) * 2002-05-31 2002-07-10 Psimedica Ltd Orthopaedic scaffolds for tissue engineering
US7299805B2 (en) 2002-06-07 2007-11-27 Marctec, Llc Scaffold and method for implanting cells
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
CA2489823A1 (en) * 2002-06-20 2003-12-31 Doxa Aktiebolag System for a dental filling material or implant material, and powdered material, hydration liquid, implant material and method of achieving bonding
US7550004B2 (en) * 2002-08-20 2009-06-23 Cook Biotech Incorporated Endoluminal device with extracellular matrix material and methods
IL152030A0 (en) * 2002-09-30 2003-05-29 Nvr Labs Ltd Neural & Vascular Cohesive biopolymers comprising sulfated polysaccharides and fibrillar proteins and use thereof for tissue repair
PL377477A1 (pl) 2002-12-11 2006-02-06 Ferrosan A/S Materiały na bazie żelatyny jako waciki
US6982298B2 (en) 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8137688B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8138265B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US7465766B2 (en) 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
DE10318801A1 (de) * 2003-04-17 2004-11-04 Aesculap Ag & Co. Kg Flächiges Implantat und seine Verwendung in der Chirurgie
JP4708342B2 (ja) 2003-07-25 2011-06-22 デックスコム・インコーポレーテッド 埋設可能な装置に用いる酸素増大膜システム
SE0302652D0 (sv) * 2003-10-06 2003-10-06 Amersham Biosciences Ab Attachment of cells to surfaces
ES2522575T3 (es) * 2003-10-22 2014-11-17 Encelle, Inc. Composiciones de hidrogel bioactivo para la regeneración del tejido conjuntivo
JP4510425B2 (ja) * 2003-10-30 2010-07-21 静志 永森 三次元培養による細胞の培養方法
CA2544726C (en) * 2003-11-07 2018-06-26 University Of Connecticut Artificial tissue systems and uses thereof
CA2536041A1 (en) * 2003-11-10 2005-05-26 Angiotech International Ag Medical implants and fibrosis-inducing agents
US20050208095A1 (en) * 2003-11-20 2005-09-22 Angiotech International Ag Polymer compositions and methods for their use
AR054637A1 (es) 2004-01-30 2007-07-11 Ferrosan As Aerosoles y composiciones hemostaticas
FR2865737B1 (fr) * 2004-02-03 2006-03-31 Anteis Sa Gel reticule biocompatible
DE102004019241A1 (de) * 2004-04-16 2005-11-03 Cellmed Ag Injizierbare vernetzte und unvernetzte Alginate und ihre Verwendung in der Medizin und in der ästhetischen Chirurgie
US9011329B2 (en) 2004-04-19 2015-04-21 Searete Llc Lumenally-active device
US8000784B2 (en) 2004-04-19 2011-08-16 The Invention Science Fund I, Llc Lumen-traveling device
US8024036B2 (en) 2007-03-19 2011-09-20 The Invention Science Fund I, Llc Lumen-traveling biological interface device and method of use
US8092549B2 (en) 2004-09-24 2012-01-10 The Invention Science Fund I, Llc Ciliated stent-like-system
US8512219B2 (en) 2004-04-19 2013-08-20 The Invention Science Fund I, Llc Bioelectromagnetic interface system
US8353896B2 (en) 2004-04-19 2013-01-15 The Invention Science Fund I, Llc Controllable release nasal system
US8337482B2 (en) 2004-04-19 2012-12-25 The Invention Science Fund I, Llc System for perfusion management
US7850676B2 (en) 2004-04-19 2010-12-14 The Invention Science Fund I, Llc System with a reservoir for perfusion management
US8361013B2 (en) 2004-04-19 2013-01-29 The Invention Science Fund I, Llc Telescoping perfusion management system
US20050245905A1 (en) * 2004-04-30 2005-11-03 Schmidt Steven P Local drug-delivery system
US8696564B2 (en) 2004-07-09 2014-04-15 Cardiac Pacemakers, Inc. Implantable sensor with biocompatible coating for controlling or inhibiting tissue growth
EP1786480B1 (de) 2004-07-09 2016-09-21 Ferrosan Medical Devices A/S Hämostatische zusammensetzung mit hyaluronsäure
FR2877669B1 (fr) * 2004-11-05 2007-01-26 Inst Nat Sciences Appliq Greffage covalent de substances hydrophobes sur le collagene
US20090088846A1 (en) 2007-04-17 2009-04-02 David Myung Hydrogel arthroplasty device
ITTO20040918A1 (it) * 2004-12-29 2005-03-29 Luigi Ambrosio Idrogel polimerici superassorbenti biodegradabili e procedimento per la loro preparazione
WO2006079928A2 (en) * 2005-01-31 2006-08-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Polyelectrolyte multilayer film, preparation and uses thereof
EP1853278A4 (de) * 2005-02-18 2011-12-28 Cartilix Inc Glucosaminmaterialien
CN101160144A (zh) * 2005-02-23 2008-04-09 苏尔莫迪克斯公司 具有层粘连蛋白涂层的可植入的医学制品和使用方法
EP1851268A4 (de) * 2005-02-23 2011-02-16 Univ California Flexible, funktionelle verbundwerkstoffe auf hydrogelbasis
CA2604856A1 (en) * 2005-04-25 2006-11-02 Eric F. Bernstein Dermal fillers for biomedical applications in mammals and methods of using the same
US20100056462A1 (en) * 2005-05-13 2010-03-04 Netech Inc. Medical composition for promotion of skin regeneration
US8475886B2 (en) * 2005-08-05 2013-07-02 Corning Incorporated Methods for producing surfaces that resist non-specific protein binding and cell attachment
US7947759B2 (en) * 2005-08-08 2011-05-24 Angstrom Medica Cement products and methods of making and using the same
EP1935438A4 (de) * 2005-09-16 2011-10-19 St Marianna University School Of Medicine Biologisches material für die regenerative medizin
CN101443044A (zh) * 2005-09-22 2009-05-27 哈达斯特医学研究服务与开发有限公司 治疗活性化合物的葡聚糖和阿拉伯半乳聚糖结合物
US20070190165A1 (en) * 2005-10-21 2007-08-16 Brey Eric M Tissue-specific basement membrane gels
WO2007050314A2 (en) * 2005-10-24 2007-05-03 Hosheng Tu Medical device with living cell sheet
TWI363800B (en) * 2006-02-06 2012-05-11 Univ Tamkang Biomedical device having crosslinked biopolymer micro pattern and preparation thereof
JP5116697B2 (ja) * 2006-02-27 2013-01-09 エドワーズ ライフサイエンシーズ コーポレイション 静脈内電流測定バイオセンサのためのヒドロゲル
US20120035438A1 (en) 2006-04-12 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Path selection by a lumen traveling device in a body tub tree based on previous path
US8936629B2 (en) 2006-04-12 2015-01-20 Invention Science Fund I Llc Autofluorescent imaging and target ablation
US8021677B2 (en) * 2006-05-12 2011-09-20 Gore Enterprise Holdings, Inc. Immobilized biologically active entities having a high degree of biological activity
US20080108138A1 (en) * 2006-06-13 2008-05-08 Vermette Patrick Bioactive compositions and their use in cell patterning
CN101500623B (zh) 2006-06-15 2016-08-24 微温森公司 一种由可膨胀聚合物构成的栓塞器械
DE102006033167A1 (de) 2006-07-10 2008-01-24 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung eines vernetzenden medizinischen Klebers
DE102006033168A1 (de) * 2006-07-10 2008-01-17 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung
CN101528830A (zh) 2006-07-10 2009-09-09 麦德医像公司 超弹性环氧水凝胶
NZ549249A (en) * 2006-08-18 2009-10-30 Univ Massey Methods for reducing the incidence of mastitis by administration of keratin
AU2012200560B2 (en) * 2006-08-18 2014-07-31 Elanco New Zealand Method for Reducing the Incidence of Mastitis
WO2008033417A2 (en) * 2006-09-13 2008-03-20 Southeastern Medical Technologies, Llc Methods and compositions for sealing and adhering biological tissues and medical uses thereof
US7914819B1 (en) * 2006-10-19 2011-03-29 Clemson University Research Foundation Polysaccharide-based biomaterials
KR101428122B1 (ko) 2006-12-15 2014-08-07 라이프본드 엘티디. 젤라틴-트랜스글루타미나아제 지혈 드레싱 및 실란트
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
WO2008078166A2 (en) 2006-12-22 2008-07-03 Laboratoire Medidom S.A. In situ system for intra-articular chondral and osseous tissue repair
US8088097B2 (en) 2007-11-21 2012-01-03 Glumetrics, Inc. Use of an equilibrium intravascular sensor to achieve tight glycemic control
US7751863B2 (en) 2007-02-06 2010-07-06 Glumetrics, Inc. Optical determination of ph and glucose
WO2008096547A1 (ja) * 2007-02-07 2008-08-14 Yaizu Suisankagaku Industry Co., Ltd. 組織滞留性キトサンゲルを含有する抗腫瘍剤組成物
US8529951B1 (en) 2007-02-21 2013-09-10 Anand Ramamurthi Elastogenic cues and methods for using same
US8679859B2 (en) * 2007-03-12 2014-03-25 State of Oregon by and through the State Board of Higher Education on behalf of Porland State University Method for functionalizing materials and devices comprising such materials
WO2008141241A1 (en) 2007-05-10 2008-11-20 Glumetrics, Inc. Equilibrium non-consuming fluorescence sensor for real time intravascular glucose measurement
DE602007010434D1 (de) * 2007-06-01 2010-12-23 Allergan Inc Gerät zur Erzeugung des zugspannungsinduzierten Wachstums von biologischem Gewebe
EP2162283B1 (de) 2007-06-14 2015-08-12 Massachusetts Institute of Technology Selbstaufbauende filme für protein- und arzneimittelabgabeanwendungen
US8932619B2 (en) * 2007-06-27 2015-01-13 Sofradim Production Dural repair material
US8480651B2 (en) * 2007-08-02 2013-07-09 Covidien Lp Cannula system
CA2696255C (en) * 2007-08-14 2016-11-29 Commonwealth Scientific And Industrial Research Organisation Photoactivated crosslinking of a protein or peptide
EP2192886B1 (de) 2007-08-28 2017-12-20 Pioneer Surgical Technology, Inc. Zementprodukte sowie verfahren zu deren herstellung und verwendung
US20090068250A1 (en) 2007-09-07 2009-03-12 Philippe Gravagna Bioresorbable and biocompatible compounds for surgical use
US20100285086A1 (en) * 2007-10-09 2010-11-11 Lee Mark H Biomimetic Extracellular Matrices
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
CA2702173C (en) * 2007-10-10 2017-03-28 Kyoto University Preparation for treating heart disease used in cell therapy
EP2222159B1 (de) 2007-11-20 2018-02-21 Pioneer Surgical Orthobiologics, Inc. Kryokonservierung von zellen mittels vernetzten bioaktiven hydrogel matrixteilchen
US9308068B2 (en) 2007-12-03 2016-04-12 Sofradim Production Implant for parastomal hernia
WO2009073734A2 (en) 2007-12-03 2009-06-11 Medipacs, Inc. Fluid metering device
EP2266639B1 (de) 2007-12-21 2016-10-05 MicroVention, Inc. Verfahren zur Herstellung von Hydrogelfilamenten für den biomedizinischen Einsatz
EP2249891B1 (de) 2008-02-13 2016-05-25 The Cleveland Clinic Foundation Molekulare verstärkung von extrazellulärer matrix und anwendungsverfahren
EP2247645B1 (de) * 2008-02-13 2017-12-06 Hyperbranch Medical Technology, Inc. Vernetzte polyalkylenimin-hydrogele mit einstellbaren degradationsraten
WO2009109194A2 (en) 2008-02-29 2009-09-11 Ferrosan A/S Device for promotion of hemostasis and/or wound healing
US8410180B2 (en) 2008-04-30 2013-04-02 The Cleveland Clinic Foundation Methods to treat urinary incontinence
JP5450612B2 (ja) 2008-06-18 2014-03-26 ライフボンド リミテッド 改良された架橋組成物
US9242026B2 (en) 2008-06-27 2016-01-26 Sofradim Production Biosynthetic implant for soft tissue repair
PL3357519T3 (pl) * 2008-07-02 2019-09-30 Allergan, Inc. Kompozycje do wypełniania i regeneracji tkanki miękkiej
US20120209396A1 (en) 2008-07-07 2012-08-16 David Myung Orthopedic implants having gradient polymer alloys
AU2009279716A1 (en) 2008-08-05 2010-02-11 Biomimedica, Inc Polyurethane-grafted hydrogels
EP2324064B1 (de) 2008-09-02 2017-11-08 Tautona Group LP Stränge aus hyaluronsäure und/oder derivaten daraus, herstellungsverfahren und verwendung
ES2553591T3 (es) * 2008-10-21 2015-12-10 Spinewelding Ag Dispositivo de fusión y conjunto de herramientas para la fusión de una articulación humana o animal
CA2746781C (en) 2008-12-17 2017-03-28 The Johns Hopkins University Biocompatible polysaccharide-based hydrogels
US8469779B1 (en) 2009-01-02 2013-06-25 Lifecell Corporation Method for debristling animal skin
US20100249924A1 (en) * 2009-03-27 2010-09-30 Allergan, Inc. Bioerodible matrix for tissue involvement
EP2236520A1 (de) * 2009-03-31 2010-10-06 Leukocare Ag Stabilisierungszusammensetzung für immobilisierte Biomoleküle
US9078712B2 (en) 2009-04-15 2015-07-14 Warsaw Orthopedic, Inc. Preformed drug-eluting device to be affixed to an anterior spinal plate
US9414864B2 (en) 2009-04-15 2016-08-16 Warsaw Orthopedic, Inc. Anterior spinal plate with preformed drug-eluting device affixed thereto
US9463260B2 (en) * 2009-06-29 2016-10-11 Covidien Lp Self-sealing compositions
FR2949688B1 (fr) 2009-09-04 2012-08-24 Sofradim Production Tissu avec picots revetu d'une couche microporeuse bioresorbable
WO2011032011A1 (en) 2009-09-10 2011-03-17 Medipacs, Inc. Low profile actuator and improved method of caregiver controlled administration of therapeutics
WO2011040969A1 (en) * 2009-09-30 2011-04-07 Massachusetts Institute Of Technology Compositions and methods for the treatment of atherosclerosis and other related diseases
JP2013506503A (ja) 2009-09-30 2013-02-28 グルメトリクス， インコーポレイテッド 抗血栓性コーティングを備えたセンサー
US20110093057A1 (en) * 2009-10-16 2011-04-21 Confluent Surgical, Inc. Mitigating Thrombus Formation On Medical Devices By Influencing pH Microenvironment Near The Surface
KR101745748B1 (ko) 2009-10-26 2017-06-12 마이크로벤션, 인코포레이티드 팽창성 중합체로부터 제작된 색전술 장치
US8467843B2 (en) 2009-11-04 2013-06-18 Glumetrics, Inc. Optical sensor configuration for ratiometric correction of blood glucose measurement
AU2010314994B2 (en) 2009-11-09 2016-10-06 Spotlight Technology Partners Llc Fragmented hydrogels
WO2011057131A1 (en) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Polysaccharide based hydrogels
CA2780490C (en) 2009-11-10 2021-01-26 The Johns Hopkins University Hydrogel-based vascular lineage cell growth media and uses thereof
BR112012015029A2 (pt) 2009-12-22 2017-06-27 Lifebond Ltd matriz reticulada, método para controlar a formação de uma matriz, método ou matriz, método para vedar um tecido contra vazamento de um fluído corporal, agente hemostático ou vedante cirúrgico, composição para vedar um ferimento, uso da composição, composição para um veículo para entrega localizada de fármaco, composição para engenharia de tecido, e método para modificar uma composição
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US20130172985A1 (en) * 2010-01-15 2013-07-04 University Of Utah Research Foundation Crosslinked hydrogels and methods of making and using thereof
US8399044B2 (en) * 2010-01-21 2013-03-19 Snu R And Db Foundation Method for coating medication on medical article
US9500186B2 (en) 2010-02-01 2016-11-22 Medipacs, Inc. High surface area polymer actuator with gas mitigating components
US20130045277A1 (en) * 2010-02-03 2013-02-21 Tetsushi Taguchi Biocompatible device
US20110229457A1 (en) * 2010-03-12 2011-09-22 Surmodics, Inc. Injectable drug delivery system
ES2729994T3 (es) 2010-03-22 2019-11-07 Allergan Inc Hidrogeles reticulados de polisacárido y proteína-polisacárido para aumento de tejido blando
US10143776B2 (en) 2010-06-30 2018-12-04 The Johns Hopkins University Functional vascularization with biocompatible polysaccharide-based hydrogels
US8961544B2 (en) 2010-08-05 2015-02-24 Lifebond Ltd. Dry composition wound dressings and adhesives comprising gelatin and transglutaminase in a cross-linked matrix
WO2012024072A1 (en) 2010-08-19 2012-02-23 Allergan, Inc. Compositions comprising adipose tissue and a pge2 analogue and their use in the treatment of a soft tissue condition
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
EP2609154B1 (de) 2010-08-27 2020-04-22 Hyalex Orthopaedics, Inc. Aus hydrophoben polymeren gewonnene interpenetrierende hydrophobe und hydrophile polymernetzwerke sowie verfahren zu ihrer herstellung
US8945664B1 (en) 2010-10-29 2015-02-03 Greatbatch Ltd. Mechanical stability of the biomimetic coating by cross linking of surfactant polymer
WO2012061556A1 (en) 2010-11-03 2012-05-10 Flugen, Inc. Wearable drug delivery device having spring drive and sliding actuation mechanism
CA2817584C (en) 2010-11-15 2018-01-02 Zimmer Orthobiologics, Inc. Bone void fillers
US8551525B2 (en) 2010-12-23 2013-10-08 Biostructures, Llc Bone graft materials and methods
US8637067B1 (en) 2011-03-10 2014-01-28 Lifecell Corporation Elastic tissue matrix derived hydrogel
FR2972626B1 (fr) 2011-03-16 2014-04-11 Sofradim Production Prothese comprenant un tricot tridimensionnel et ajoure
EP2508212A1 (de) 2011-04-05 2012-10-10 Universitätsklinikum Freiburg Biokompatibles und biologisch abbaubares Gradientenschichtsystem für die regenerative Medizin und zur Gewebeunterstützung
US9375513B2 (en) 2011-04-14 2016-06-28 Lifecell Corporation Regenerative materials
US9456823B2 (en) 2011-04-18 2016-10-04 Terumo Corporation Embolic devices
EP2701908A4 (de) * 2011-04-27 2014-11-26 Massachusetts Inst Technology Beschichtungszusammensetzungen, verfahren dafür und beschichtete vorrichtungen
ES2708076T3 (es) * 2011-05-24 2019-04-08 Symic Ip Llc Peptidoglicanos sintéticos que se unen al ácido hialurónico, preparación y métodos de uso
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
CN103702659B (zh) 2011-06-03 2016-12-21 阿勒根公司 包括抗氧化剂的皮肤填充剂组合物
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
FR2977789B1 (fr) 2011-07-13 2013-07-19 Sofradim Production Prothese pour hernie ombilicale
FR2977790B1 (fr) 2011-07-13 2013-07-19 Sofradim Production Prothese pour hernie ombilicale
US9089523B2 (en) 2011-07-28 2015-07-28 Lifecell Corporation Natural tissue scaffolds as tissue fillers
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
CA2850148C (en) 2011-09-27 2020-02-25 Glumetrics, Inc. Method for functionalizing a porous membrane covering of an optical sensor to facilitate coupling of an antithrombogenic agent
WO2013046058A2 (en) 2011-09-30 2013-04-04 Sofradim Production Reversible stiffening of light weight mesh
AU2012313983B2 (en) 2011-09-30 2017-01-19 Sofradim Production Multilayer implants for delivery of therapeutic agents
AU2012319183A1 (en) 2011-10-03 2014-05-22 Biomimedica, Inc. Polymeric adhesive for anchoring compliant materials to another surface
ES2687765T3 (es) * 2011-10-21 2018-10-29 Nitta Casings Inc. Materiales de colágeno-polisacárido que imitan los vasos sanguíneos, los tejidos y los huesos
CN104010669A (zh) * 2011-10-28 2014-08-27 巴克斯特国际公司 用于骨骼止血的非水性组合物以及它们的使用和制造方法
WO2013067195A1 (en) 2011-11-02 2013-05-10 Halscion, Inc. Methods and compositions for wound treatment
IN2014CN03524A (de) * 2011-11-13 2015-10-09 Suneris Inc
EP2782524B1 (de) 2011-11-21 2017-12-20 Biomimedica, Inc Systeme zum verankern orthopädischer implantate in knochen
BR112014014975B1 (pt) 2011-12-20 2019-06-25 Lifecell Corporation Produto de tecido, e método para produzir uma composição de tecido
ES2729712T3 (es) 2011-12-20 2019-11-05 Lifecell Corp Productos de tejido de lámina
WO2013096650A2 (en) 2011-12-23 2013-06-27 Pioneer Surgical Technology Continuous matrix with osteoconductive particles dispersed therein, method of forming thereof, and method of regenerating bone therewith
FR2985170B1 (fr) 2011-12-29 2014-01-24 Sofradim Production Prothese pour hernie inguinale
FR2985271B1 (fr) 2011-12-29 2014-01-24 Sofradim Production Tricot a picots
ES2705823T3 (es) 2012-01-24 2019-03-26 Lifecell Corp Matrices de tejidos alargadas
JP6241624B2 (ja) 2012-03-06 2017-12-06 フェロサン メディカル デバイシーズ エイ／エス 止血ペーストを収容する加圧容器
CA2906274A1 (en) 2012-03-14 2013-09-19 Medipacs, Inc. Smart polymer materials with excess reactive molecules
WO2013158781A1 (en) 2012-04-18 2013-10-24 Microvention, Inc. Embolic devices
US10278927B2 (en) 2012-04-23 2019-05-07 Massachusetts Institute Of Technology Stable layer-by-layer coated particles
CA2871665A1 (en) 2012-04-24 2013-10-31 Lifecell Corporation Flowable tissue matrices
JP6394916B2 (ja) 2012-06-12 2018-09-26 フェロサン メディカル デバイシーズ エイ／エス 乾燥止血組成物
CN104363922B (zh) 2012-06-14 2017-06-30 微仙美国有限公司 聚合物治疗组合物
WO2013191510A1 (ko) * 2012-06-22 2013-12-27 서울대학교 산학협력단 체내 이동방지 수단이 구비된 체내 삽입 의료용 금속물질
US11090338B2 (en) 2012-07-13 2021-08-17 Lifecell Corporation Methods for improved treatment of adipose tissue
CN102784164A (zh) * 2012-07-27 2012-11-21 中国海洋大学 藻酸双酯钠在制备治疗肿瘤的新血管生成抑制剂和血管破坏剂中的应用
FR2994185B1 (fr) 2012-08-02 2015-07-31 Sofradim Production Procede de preparation d’une couche poreuse a base de chitosane
WO2014039995A1 (en) 2012-09-07 2014-03-13 Fibrocell Technologies, Inc. Fibroblast compositions for treating cardial damage after an infarct
WO2014048564A1 (en) * 2012-09-25 2014-04-03 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. "novel cross-linkers for hydrogels, hydrogels including these cross-linkers and applications thereof"
FR2995788B1 (fr) 2012-09-25 2014-09-26 Sofradim Production Patch hemostatique et procede de preparation
FR2995779B1 (fr) 2012-09-25 2015-09-25 Sofradim Production Prothese comprenant un treillis et un moyen de consolidation
FR2995778B1 (fr) 2012-09-25 2015-06-26 Sofradim Production Prothese de renfort de la paroi abdominale et procede de fabrication
CA2885327A1 (en) 2012-09-26 2014-04-03 Lifecell Corporation Processed adipose tissue
AU2013322268B2 (en) 2012-09-28 2017-08-31 Sofradim Production Packaging for a hernia repair device
AU2013331439B2 (en) 2012-10-15 2016-05-12 Microvention, Inc. Polymeric treatment compositions
US20150283296A1 (en) * 2012-12-18 2015-10-08 Novabone Products Llc Bioactive glass with ethylene oxide proplyene oxide block copolymers
CN103007346A (zh) * 2012-12-26 2013-04-03 天津市赛宁生物工程技术有限公司 物理沉降法制备的防粘连硬脑膜
EP3848064A1 (de) 2012-12-28 2021-07-14 Boston Scientific Scimed, Inc. Kits für chirurgische reparatur
US9446166B2 (en) 2013-01-24 2016-09-20 Ethicon, Inc. Fibrin sealant compositions with chemical crosslinking
EP3659633A1 (de) 2013-02-06 2020-06-03 LifeCell Corporation Verfahren für lokalisierte modifizierung von gewebeprodukten
US9347037B2 (en) * 2013-02-11 2016-05-24 Evan Masataka Masutani Methods and apparatus for building complex 3D scaffolds and biomimetic scaffolds built therefrom
WO2014134029A1 (en) 2013-02-26 2014-09-04 Massachusetts Institute Of Technology Nucleic acid particles, methods and use thereof
US9867939B2 (en) 2013-03-12 2018-01-16 Allergan, Inc. Adipose tissue combinations, devices, and uses thereof
US10130288B2 (en) 2013-03-14 2018-11-20 Cell and Molecular Tissue Engineering, LLC Coated sensors, and corresponding systems and methods
US10405961B2 (en) 2013-03-14 2019-09-10 Cell and Molecular Tissue Engineering, LLC Coated surgical mesh, and corresponding systems and methods
WO2014150074A1 (en) 2013-03-15 2014-09-25 Massachusetts Institute Of Technology Compositions and methods for nucleic acid delivery
US20140350516A1 (en) 2013-05-23 2014-11-27 Allergan, Inc. Mechanical syringe accessory
FR3006578B1 (fr) 2013-06-07 2015-05-29 Sofradim Production Prothese a base d’un textile pour voie laparoscopique
FR3006581B1 (fr) 2013-06-07 2016-07-22 Sofradim Production Prothese a base d’un textile pour voie laparoscopique
GB201310894D0 (en) 2013-06-19 2013-07-31 Univ Singapore Surface modification of medical or veterinary devices
AU2014283170B2 (en) 2013-06-21 2017-11-02 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US9290115B2 (en) 2013-09-10 2016-03-22 Bae Industries, Inc. Seat assembly with moveable seatback
EP3052083A4 (de) 2013-09-30 2017-05-03 Bioactive Regenerative Therapeutics, Inc. Biomimetische hybridgelzusammensetzungen und verfahren zur verwendung
US9248384B2 (en) 2013-10-02 2016-02-02 Allergan, Inc. Fat processing system
CN103520764B (zh) * 2013-10-29 2015-06-03 成都迪康中科生物医学材料有限公司 功能性敷料及其制备方法和用途
KR20150053606A (ko) * 2013-11-08 2015-05-18 세원셀론텍(주) 콜라겐과 히알루론산의 천연가교를 통한 고무성질의 물성이 강화된 생체재료물질 및 그 제조방법
CN103638553A (zh) * 2013-11-27 2014-03-19 首都医科大学 具有定向通道的透明质酸水凝胶生物支架材料及制法
CA2928963C (en) 2013-12-11 2020-10-27 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US11000285B2 (en) * 2013-12-17 2021-05-11 3Dt Holdings, Llc Luminal grafts and methods of making and using the same
WO2015153996A1 (en) 2014-04-03 2015-10-08 Micro Vention, Inc. Embolic devices
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
JP6599361B2 (ja) 2014-04-29 2019-10-30 マイクロベンション インコーポレイテッド 活性剤を含むポリマー
US10029048B2 (en) 2014-05-13 2018-07-24 Allergan, Inc. High force injection devices
WO2015191547A1 (en) * 2014-06-09 2015-12-17 Cornell University Implantable therapeutic delivery system and methods thereof
EP3000489B1 (de) 2014-09-24 2017-04-05 Sofradim Production Verfahren zur Herstellung einer Antihaft-Sperrschicht
EP3000432B1 (de) 2014-09-29 2022-05-04 Sofradim Production Textilbasierte Prothese für die Behandlung von Leistenbruch
EP3000433B1 (de) 2014-09-29 2022-09-21 Sofradim Production Vorrichtung zur Einführung einer Prothese zur Hernie-Behandlung in einen Einschnitt und flexible textile Prothese
US10722444B2 (en) 2014-09-30 2020-07-28 Allergan Industrie, Sas Stable hydrogel compositions including additives
JP6726852B2 (ja) 2014-10-13 2020-07-22 フェッローサン メディカル ディバイス エー／エス 止血および創傷治癒に使用するための乾燥組成物
EP3029189B1 (de) 2014-12-05 2021-08-11 Sofradim Production Prothetisches poröses Netz, sein Herstellungsverfahren und Hernienprothese
JP6747650B2 (ja) 2014-12-24 2020-08-26 フェロサン メディカル デバイシーズ エイ／エス 第１の物質と第２の物質を保持し混合するためのシリンジ
KR102609954B1 (ko) * 2015-01-12 2023-12-05 웨이크 포리스트 유니버시티 헬스 사이언시즈 다층 피부 대체재 산물 및 그의 제조 및 사용 방법
CA2974209A1 (en) 2015-02-06 2016-08-11 Aziz Ghahary Engineered tissue substitute system
EP3059255B1 (de) 2015-02-17 2020-05-13 Sofradim Production Verfahren zur Herstellung einer Matrix auf Chitosanbasis mit faseroptischem Verstärkungselement
CA2976544A1 (en) 2015-03-10 2016-09-15 Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company Multiple needle injector
US10633683B2 (en) 2015-04-03 2020-04-28 Dupont Industrial Biosciences Usa, Llc Gelling dextran ethers
US10787524B2 (en) 2015-04-03 2020-09-29 Dupont Industrial Biosciences Usa, Llc Oxidized dextran
EP3085337B1 (de) 2015-04-24 2022-09-14 Sofradim Production Prothese zur unterstützung einer bruststruktur
US10126298B2 (en) 2015-05-04 2018-11-13 Arman Nabatian Hydrogels containing embedded substrates for targeted binding of molecules
US10531957B2 (en) 2015-05-21 2020-01-14 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
WO2016201250A1 (en) 2015-06-11 2016-12-15 Microvention, Inc. Expansile device for implantation
ES2676072T3 (es) 2015-06-19 2018-07-16 Sofradim Production Prótesis sintética que comprende un tejido de punto y una película no porosa y método para formarla
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
CN107028872B (zh) * 2015-07-21 2020-05-22 中国科学院化学研究所 一种复合水凝胶、其制备方法及应用
US11077228B2 (en) 2015-08-10 2021-08-03 Hyalex Orthopaedics, Inc. Interpenetrating polymer networks
KR101734489B1 (ko) 2015-08-11 2017-05-11 (주)헵틸와이 산화 다당류 및 친수성 고분자 함유 코팅층을 포함하는 의료용 카테터 및 그 제조방법
US10173027B2 (en) * 2015-10-07 2019-01-08 Cook Medical Technologies Llc Methods, medical devices and kits for modifying the luminal profile of a body vessel
EP3821880A1 (de) 2015-10-26 2021-05-19 President and Fellows of Harvard College Oxidierte polysaccharide und verfahren zur verwendung davon
CN105363070B (zh) * 2015-11-25 2016-11-23 中国石油大学(华东) 一种可用于细胞粘附的水凝胶及其制备方法
GB201523102D0 (en) * 2015-12-30 2016-02-10 Augmented Optics Ltd Electrically active hydrophilic bio-polymers
EP3195830B1 (de) 2016-01-25 2020-11-18 Sofradim Production Prothese zur hernienreparatur
WO2017170487A1 (ja) * 2016-03-28 2017-10-05 富士フイルム株式会社 製剤、製剤用部材およびそれらの製造方法
AU2017246114B2 (en) 2016-04-08 2022-03-17 Allergan, Inc. Aspiration and injection device
SG10201913342UA (en) 2016-04-27 2020-03-30 Anika Therapeutics Inc Compositions for use in treating tendon degeneration
US9745439B1 (en) 2016-05-10 2017-08-29 Qatar Foundation For Education, Science And Community Development Methods of forming aerogels
WO2017210109A1 (en) 2016-06-03 2017-12-07 Lifecell Corporation Methods for localized modification of tissue products
US10368874B2 (en) 2016-08-26 2019-08-06 Microvention, Inc. Embolic compositions
EP3312325B1 (de) 2016-10-21 2021-09-22 Sofradim Production Verfahren zur herstellung eines netzes mit einem daran befestigten nahtmaterial mit widerhaken und dadurch erhaltenes netz
US20180133368A1 (en) * 2016-11-15 2018-05-17 The Board Of Regents Of The University Of Texas System 3D Printed Ti-6Al-4V Scaffolds with Hydrogel Matrix
US20200179569A1 (en) * 2016-11-25 2020-06-11 Stimos Gmbh Material for a bone implant and method for producing the same
JP2020501660A (ja) 2016-12-22 2020-01-23 ライフセル コーポレーションＬｉｆｅＣｅｌｌ Ｃｏｒｐｏｒａｔｉｏｎ 組織を凍結切削する装置および方法
CN107050521B (zh) * 2017-04-27 2020-10-09 天新福（北京）医疗器材股份有限公司 一种双层胶原真皮支架及其制备方法
EP3398554A1 (de) 2017-05-02 2018-11-07 Sofradim Production Prothese zur leistenbruch-reparatur
KR20200075036A (ko) * 2017-07-18 2020-06-25 모던 메도우 아이엔씨. 생제작된 가죽 물품 및 이의 방법
JP2020533070A (ja) 2017-09-08 2020-11-19 パイオニア サージカル テクノロジー インコーポレイテッド 椎間インプラント、器具、及び方法
USD907771S1 (en) 2017-10-09 2021-01-12 Pioneer Surgical Technology, Inc. Intervertebral implant
JP7362598B2 (ja) 2017-10-09 2023-10-17 マイクロベンション インコーポレイテッド 放射性液体塞栓物質
US11123375B2 (en) 2017-10-18 2021-09-21 Lifecell Corporation Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
JP7297739B2 (ja) 2017-10-18 2023-06-26 ライフセル コーポレーション 脂肪組織製品および製造方法
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
WO2019079672A1 (en) 2017-10-19 2019-04-25 Lifecell Corporation ACELLULAR TISSUE MATRIX PRODUCTS FLUIDS AND METHODS OF PRODUCTION
WO2019089567A1 (en) 2017-10-30 2019-05-09 Massachusetts Institute Of Technology Layer-by-layer nanoparticles for cytokine therapy in cancer treatment
US11376345B2 (en) 2017-11-23 2022-07-05 Sentigel Ab Hydrogel composition and its uses
JP7395113B2 (ja) 2018-05-09 2023-12-11 フェロサン メディカル デバイシーズ エイ／エス 止血組成物を調製する方法
US10869950B2 (en) 2018-07-17 2020-12-22 Hyalex Orthopaedics, Inc. Ionic polymer compositions
CN109224123B (zh) * 2018-10-11 2021-04-09 成都迪康中科生物医学材料有限公司 具有抑制肿瘤作用的纳米羟基磷灰石复合材料及制备方法
EP3653171A1 (de) 2018-11-16 2020-05-20 Sofradim Production Implantate zur weichgewebereparatur
WO2020120805A2 (en) 2018-12-14 2020-06-18 Institut Químic De Sarrià Cets Fundació Privada Heterogeneous scaffolds and methods of functionalising surfaces
US11090412B2 (en) 2018-12-21 2021-08-17 Zavation Medical Products Llc Bone repair composition and kit
US20200359943A1 (en) * 2019-05-16 2020-11-19 Senseonics, Incorporated Mediation of in vivo analyte signal degradation
CA3142151A1 (en) 2019-05-30 2020-12-03 Lifecell Corporation Biologic breast implant
WO2020252230A1 (en) * 2019-06-13 2020-12-17 The Regents Of The University Of California Osteoinductive modified gelatin hydrogels and methods of making and using the same
US11446084B2 (en) 2019-07-12 2022-09-20 Neuralink Corp. Laser drilling of pia mater
CN110787325A (zh) * 2019-09-21 2020-02-14 常州百瑞吉生物医药有限公司 用于预防腹（盆）腔术后组织粘连的二硫键交联透明质酸凝胶及其制备方法
KR102099846B1 (ko) * 2019-09-26 2020-04-14 (주)리젠바이오참 덱스트란과 단백질 복합체가 코팅된 생분해성 고분자 지지체의 제조방법
CN111171332B (zh) * 2019-12-31 2021-09-28 广州贝奥吉因生物科技股份有限公司 一种释放一氧化氮水凝胶及其制备方法
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
CN112140669A (zh) * 2020-09-22 2020-12-29 苏州经结纬面料科技有限公司 一种户外运动面料及其制备工艺
CN114644739B (zh) * 2020-12-18 2023-08-22 武汉理工大学 一种高粘附性水凝胶、制备方法及应用
CN112807483B (zh) * 2021-02-03 2022-10-21 中国药科大学 一种抗炎、抗菌、止血的双网络水凝胶及其制备方法和应用
CN115068666B (zh) * 2021-03-10 2023-12-26 广东粤港澳大湾区国家纳米科技创新研究院 一种防粘连的止血水凝胶及其制备方法和应用
CN113101264B (zh) * 2021-04-08 2022-05-03 西南交通大学 一种具有ros响应的水凝胶及其制备方法和应用
CN113425893A (zh) * 2021-07-26 2021-09-24 郑州大学 一种载药水凝胶的制备方法及其应用
CN113941026A (zh) * 2021-10-25 2022-01-18 浙江中医药大学 一种包载生物活性玻璃的壳聚糖纤维素衍生物基可注射水凝胶敷料及其制备方法
CN114767922B (zh) * 2022-03-15 2023-09-12 青岛大学 搭载益生菌的透明质酸水凝胶及其制备方法和应用
CN115844927B (zh) * 2023-03-02 2023-05-12 深圳汉盛再生医学科技有限公司 干细胞在制备治疗脑白质病的制剂中的用途
CN116036361B (zh) * 2023-03-29 2023-06-20 四川大学 一种注射水凝胶及其制备方法和应用

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4618490A (en) 1980-06-06 1986-10-21 Marco Peter T De Method of treatment of animal and human tissues damaged by burns and frank visible gangrene
SU1002356A1 (ru) 1980-12-31 1983-03-07 Всесоюзный кардиологический научный центр АМН СССР Способ получени иммобилизованного фибринолизина
US4520821A (en) 1982-04-30 1985-06-04 The Regents Of The University Of California Growing of long-term biological tissue correction structures in vivo
GB2148901A (en) * 1983-10-04 1985-06-05 Johnson & Johnson Protein/polysaccharide complexes
GB8328074D0 (en) 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compositions
DE3414924A1 (de) * 1984-04-19 1985-10-31 Klaus Dr.med. Dr.med.habil. 8000 München Draenert Beschichtetes verankerungsteil fuer implantate
US4563350A (en) 1984-10-24 1986-01-07 Collagen Corporation Inductive collagen based bone repair preparations
US4863856A (en) 1985-04-04 1989-09-05 Verax Corporation Weighted collagen microsponge for immobilizing bioactive materials
US4997753A (en) 1985-04-04 1991-03-05 Verax Corporation Weighted collagen microsponge for immobilizing bioactive material
US5100783A (en) 1985-05-10 1992-03-31 Verax Corporation Weighted microsponge for immobilizing bioactive material
US4895724A (en) 1985-06-07 1990-01-23 Pfizer Inc. Chitosan compositions for controlled and prolonged release of macromolecules
AU589438B2 (en) 1985-08-26 1989-10-12 Hana Biologics, Inc. Transplantable artificial tissue and process
US4902295A (en) 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
JPS62246371A (ja) 1986-04-19 1987-10-27 株式会社　高研 人工皮膚及びその製造方法
US5457093A (en) 1987-09-18 1995-10-10 Ethicon, Inc. Gel formulations containing growth factors
US5705485A (en) 1987-09-18 1998-01-06 Ethicon, Inc. Gel formulations containing growth factors
AU632273B2 (en) 1988-03-09 1992-12-24 Terumo Kabushiki Kaisha Medical material permitting cells to enter thereinto and artificial skin
US5350583A (en) 1988-03-09 1994-09-27 Terumo Kabushiki Kaisha Cell-penetrable medical material and artificial skin
US4950483A (en) 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5800541A (en) 1988-11-21 1998-09-01 Collagen Corporation Collagen-synthetic polymer matrices prepared using a multiple step reaction
US5306500A (en) * 1988-11-21 1994-04-26 Collagen Corporation Method of augmenting tissue with collagen-polymer conjugates
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US4957902A (en) 1988-12-20 1990-09-18 Board Of Regents, The University Of Texas System Peptide inhibitors of wound contraction
US5073373A (en) 1989-09-21 1991-12-17 Osteotech, Inc. Flowable demineralized bone powder composition and its use in bone repair
US5290558A (en) 1989-09-21 1994-03-01 Osteotech, Inc. Flowable demineralized bone powder composition and its use in bone repair
US5645591A (en) 1990-05-29 1997-07-08 Stryker Corporation Synthetic bone matrix
US5466609A (en) 1990-10-31 1995-11-14 Coulter Corporation Biodegradable gelatin-aminodextran particle coatings of and processes for making same
US5099012A (en) 1990-12-11 1992-03-24 Eastman Kodak Company Chroman-2-carboxamide conjugates and their use for treatment of reperfusion injury
CS277533B6 (en) 1990-12-29 1993-03-17 Krajicek Milan Fixed osteaosynthesis appliance
DK0585368T3 (da) 1991-04-25 1998-03-16 Univ Brown Res Found Implanterbart biokompatibelt immunisolatorisk vehikel til afgivelse af udvalgte terapeutiske produkter
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US5591709A (en) 1991-08-30 1997-01-07 Life Medical Sciences, Inc. Compositions and methods for treating wounds
AU636544B1 (en) * 1991-11-27 1993-04-29 Lignyte Co., Ltd. Water insoluble biocompatible hyaluronic acid polyion complex and method of making the same
US5830492A (en) 1992-02-24 1998-11-03 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US5824331A (en) 1992-02-24 1998-10-20 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US6231881B1 (en) * 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
US6352707B1 (en) 1992-02-24 2002-03-05 Anton-Lewis Usala Transplant encapsulation in a hydrogel matrix to obscure immune recognition
CA2109065C (en) 1992-02-24 2004-03-30 Anton-Lewis Usala Bioartificial endocrine device
US5834005A (en) 1992-02-24 1998-11-10 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US5514379A (en) * 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
DE69434626D1 (de) 1993-11-17 2006-04-20 Athena Neurosciences Inc Transparente flüssigkeit zur verabreichung von verkapselten medikamenten
US5569468A (en) 1994-02-17 1996-10-29 Modi; Pankaj Vaccine delivery system for immunization, using biodegradable polymer microspheres
ATE310839T1 (de) 1994-04-29 2005-12-15 Scimed Life Systems Inc Stent mit kollagen
US5783214A (en) 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
SE503711C2 (sv) * 1994-12-14 1996-08-12 Medicarb Ab Flerstegsförfarande för beläggning av en intraokulär lins
US5716404A (en) 1994-12-16 1998-02-10 Massachusetts Institute Of Technology Breast tissue engineering
US5733337A (en) 1995-04-07 1998-03-31 Organogenesis, Inc. Tissue repair fabric
US5830879A (en) * 1995-10-02 1998-11-03 St. Elizabeth's Medical Center Of Boston, Inc. Treatment of vascular injury using vascular endothelial growth factor
US6833408B2 (en) * 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
CA2251129A1 (en) * 1996-05-03 1997-11-13 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
US5718012A (en) 1996-05-28 1998-02-17 Organogenesis, Inc. Method of strength enhancement of collagen constructs
FR2754268B1 (fr) 1996-10-07 1998-12-24 Dev Des Utilisations Du Collag Composition adhesive a base de polyaldehyde macromoleculaire et procede de reticulation de collagene ou de gelatine
US5756715A (en) 1996-11-08 1998-05-26 Abbott Laboratories Process for making crystalline iron dextran
US6011008A (en) 1997-01-08 2000-01-04 Yissum Research Developement Company Of The Hebrew University Of Jerusalem Conjugates of biologically active substances
US5866165A (en) 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
US6582472B2 (en) * 1997-02-26 2003-06-24 Applied Medical Resources Corporation Kinetic stent
US5972332A (en) 1997-04-16 1999-10-26 The Regents Of The University Of Michigan Wound treatment with keratinocytes on a solid support enclosed in a porous material
US5993844A (en) 1997-05-08 1999-11-30 Organogenesis, Inc. Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
EP0986408B1 (de) 1997-06-03 2005-05-11 Innogenetics N.V. Neue arzneimittel auf der basis von polymeren aus mit methacrylamid modifizierter gelatine
US6077916A (en) 1997-06-04 2000-06-20 The Penn State Research Foundation Biodegradable mixtures of polyphoshazene and other polymers
WO1999001143A1 (en) 1997-07-03 1999-01-14 Orquest, Inc. Cross-linked polysaccharide drug carrier
US6471993B1 (en) * 1997-08-01 2002-10-29 Massachusetts Institute Of Technology Three-dimensional polymer matrices
US5922339A (en) 1998-01-27 1999-07-13 Usala; Anton-Lewis Compositions and methods for biocompatible implants
US6378527B1 (en) * 1998-04-08 2002-04-30 Chondros, Inc. Cell-culture and polymer constructs
GB9902652D0 (en) 1999-02-05 1999-03-31 Fermentech Med Ltd Process
US6299448B1 (en) * 1999-02-17 2001-10-09 Ivanka J. Zdrahala Surgical implant system for restoration and repair of body function
FR2794649B1 (fr) * 1999-06-11 2003-04-11 Solutions Biomateriau a base d'un derive de dextrane insolubilise et d'un facteur de croissance, son procede de preparation et ses applications
EP1142596A1 (de) 2000-04-03 2001-10-10 Universiteit Gent Zusammensetzung von vernetzbaren Prepolymeren zum Gebrauch in therapeutisch aktiven, bioabbaubaren Implantaten
US6682760B2 (en) 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
JP2001316285A (ja) * 2000-05-01 2001-11-13 Yasuhiko Tabata 細胞と細胞増殖因子とからなる組織器官の再生のための材料
CA2428748A1 (en) * 2000-11-14 2002-05-23 N.V.R. Labs Bvi Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants
JP4624678B2 (ja) * 2002-02-21 2011-02-02 パイオニア・サージカル・オーソバイオロジックス，インコーポレイテッド 架橋生物活性ヒドロゲルマトリックス

Also Published As

Publication number Publication date
AU2003213253A2 (en) 2003-09-09
ATE410198T1 (de) 2008-10-15
AU2003213253A1 (en) 2003-09-09
ATE420672T1 (de) 2009-01-15
US20120076868A1 (en) 2012-03-29
EP1476204A1 (de) 2004-11-17
ES2318115T3 (es) 2009-05-01
CA2476653C (en) 2009-01-27
EP1476202A1 (de) 2004-11-17
JP4624678B2 (ja) 2011-02-02
EP1476202B1 (de) 2009-01-14
NZ535369A (en) 2006-02-24
NZ535136A (en) 2006-03-31
US7303814B2 (en) 2007-12-04
DE60325827D1 (de) 2009-03-05
US8957050B2 (en) 2015-02-17
US20150140116A1 (en) 2015-05-21
AU2003215330A1 (en) 2003-09-09
US20080199508A1 (en) 2008-08-21
US9623146B2 (en) 2017-04-18
US20030232746A1 (en) 2003-12-18
US20130189371A1 (en) 2013-07-25
AU2003215330B2 (en) 2008-03-13
US8664202B2 (en) 2014-03-04
AU2003213253B2 (en) 2008-04-10
US8053423B2 (en) 2011-11-08
US20030232198A1 (en) 2003-12-18
US10265436B2 (en) 2019-04-23
WO2003072157A1 (en) 2003-09-04
CA2476653A1 (en) 2003-09-04
EP1476204B1 (de) 2008-10-08
CA2476656A1 (en) 2003-09-04
JP2005528933A (ja) 2005-09-29
JP2005524425A (ja) 2005-08-18
US8609122B2 (en) 2013-12-17
ES2314187T3 (es) 2009-03-16
WO2003072155A1 (en) 2003-09-04
US20170182215A1 (en) 2017-06-29
US20140066694A1 (en) 2014-03-06
US9610382B2 (en) 2017-04-04
JP4489437B2 (ja) 2010-06-23
US7799767B2 (en) 2010-09-21
CA2476656C (en) 2008-11-25
US20100226961A1 (en) 2010-09-09

Similar Documents

Publication Publication Date Title
ATE410198T1 (de) Immobilisierte bioaktive hydrogel matrizen für oberflächenbeschichtungen
BR0013294A (pt) Composições de revestimento tendo resistência a arranhamento aperfeiçoada, substratos revestidos e métodos relacionados a eles
ATE357938T1 (de) Antibiotische hydrophile beschichtung
BRPI0511346A (pt) artigo compreendendo uma superfìcie, revestimento em multicamadas, substrato, material refletivo e sistema de revestimento em multicamadas
DE60203931D1 (de) Methode zum verbinden einer glasscheibe mit einem substrat ohne verwendung eines primers
WO2008103668A3 (en) Silane coating compositions, coating systems, and methods
DE60334650D1 (de) Dünnfilmbeschichtung mit einer transparenten Grundierungsschicht
DE69824449D1 (de) Inhibierung von fäulnis
AU5658498A (en) Method for coating substrates, preferably with metal
ATE236203T1 (de) Silancopolymer-beschichtungen
US11904351B2 (en) Product with protective coating and manufacturing method thereof
BRPI0621069B1 (pt) composição impregnante,substrato poroso e método para revestir pelo menos parcialmente um substrato poroso
TW200724616A (en) Compositions containing a silanol functional polymer and related hydrophilic coating films
TW200520609A (en) Mask, method for manufacturing thereof, method for manufacturing organic electroluminescent device, and organic electroluminescent device
DE60304163D1 (de) Herstellung von beschichtungen durch plasmapolymerisation
BR112021020724A2 (pt) Artigo compreendendo um substrato revestido e método para revestir um substrato
EA201190323A1 (ru) Защитное покрытие, способ защиты подложки и применение этого способа
DE50212291D1 (de) Beschichtungsverfahren und beschichtungsmittel
ATE302174T1 (de) An hydrophobe substrate gebundene hydrophile schutzschichten für hochtemperaturanwendungen
ATE271929T1 (de) Verfahren zur haftfesten beschichtung von substraten mit korrosiven optischen schichten
MXPA04000931A (es) Reticulantes de aminoplast modificados y composiciones de recubrimiento en polvo que contienen dichos reticulantes,.
ATE422579T1 (de) Übertragung von pulverteilchen auf eine faserbahn
ATE362405T1 (de) Kratzfestausrüstung für beschichtete substrate
TW200724573A (en) Polymer compound for improving hydrophobicity of substrate and coating composition containing the same
TH44192A (th) สารเคลือบผิวชนิดไซเลนสำหรับการส่งเสริมการยึดติด

Legal Events

Date Code Title Description
8364 No opposition during term of opposition